Entity Common Stock, Shares Outstanding of ImmunoGen, Inc. from 25 Oct 2011 to 25 Oct 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ImmunoGen, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 25 Oct 2011 to 25 Oct 2023.
  • ImmunoGen, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 25 Oct 2023 was 266,264,274, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ImmunoGen, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 266,264,274 +45,513,346 +21% 25 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 248,943,426 +28,230,336 +13% 25 Jul 2023 10-Q 31 Jul 2023 2023 Q2
Q1 2023 226,070,419 +5,534,387 +2.5% 21 Apr 2023 10-Q 28 Apr 2023 2023 Q1
Q3 2022 220,750,928 +18,131,440 +8.9% 31 Oct 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 220,713,090 +19,087,754 +9.5% 25 Jul 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 220,536,032 +20,593,880 +10% 02 May 2022 10-Q 06 May 2022 2022 Q1
Q3 2021 202,619,488 +15,091,740 +8% 26 Oct 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 201,625,336 +27,083,221 +16% 27 Jul 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 199,942,152 +25,621,215 +15% 30 Apr 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 187,527,748 +37,832,424 +25% 30 Oct 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 174,542,115 +24,657,299 +16% 30 Jul 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 174,320,937 +24,789,991 +17% 04 Mar 2020 10-K 11 Mar 2020 2019 FY
Q3 2019 149,695,324 +604,554 +0.4% 31 Oct 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 149,884,816 +863,493 +0.58% 31 Jul 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 149,530,946 +16,494,000 +12% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 149,090,770 +16,840,090 +13% 29 Oct 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 149,021,323 +59,423,553 +66% 31 Jul 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 133,036,946 +43,688,557 +49% 30 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 132,250,680 +44,949,339 +51% 31 Oct 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 89,597,770 01 Aug 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 89,348,389 +2,271,411 +2.6% 01 May 2017 10-Q 05 May 2017 2017 Q1
Q3 2016 87,301,341 +316,711 +0.36% 27 Oct 2016 10-Q 04 Nov 2016 2017 Q1
Q1 2016 87,076,978 +891,921 +1% 28 Apr 2016 10-Q 04 May 2016 2016 Q3
Q4 2015 87,060,869 +953,018 +1.1% 29 Jan 2016 10-Q 04 Feb 2016 2016 Q2
Q3 2015 86,984,630 +1,048,996 +1.2% 27 Oct 2015 10-Q 30 Oct 2015 2016 Q1
Q1 2015 86,185,057 +371,324 +0.43% 30 Apr 2015 10-Q 08 May 2015 2015 Q3
Q4 2014 86,107,851 +435,135 +0.51% 29 Jan 2015 10-Q 05 Feb 2015 2015 Q2
Q3 2014 85,935,634 +540,378 +0.63% 23 Oct 2014 10-Q 30 Oct 2014 2015 Q1
Q1 2014 85,813,733 +1,279,924 +1.5% 23 Apr 2014 10-Q 02 May 2014 2014 Q3
Q4 2013 85,672,716 +1,450,692 +1.7% 27 Jan 2014 10-Q 05 Feb 2014 2014 Q2
Q3 2013 85,395,256 +1,274,727 +1.5% 21 Oct 2013 10-Q 29 Oct 2013 2014 Q1
Q1 2013 84,533,809 +7,238,734 +9.4% 29 Apr 2013 10-Q 06 May 2013 2013 Q3
Q4 2012 84,222,024 +7,468,148 +9.7% 22 Jan 2013 10-Q 30 Jan 2013 2013 Q2
Q3 2012 84,120,529 +7,684,613 +10% 24 Oct 2012 10-Q 31 Oct 2012 2013 Q1
Q1 2012 77,295,075 01 May 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 76,753,876 26 Jan 2012 10-Q 31 Jan 2012 2012 Q2
Q3 2011 76,435,916 25 Oct 2011 10-Q 31 Oct 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.